HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

folic acid- poly(ethyleneglycol)- 2- distearoylglycero- 3- phosphoethanolamine

a drug carrier; structure in first source

Also Known As:

FA-PEG-hyd-DSPE; folic acid-poly(ethyleneglycol)-2-distearoyl-sn-glycero-3-phosphoethanolamine

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Pteridines: 147
      - Pterins: 160
        Folic Acid: 19425
        folic acid-poly(ethyleneglycol)-2-distearoylglycero-3-phosphoethanolamine: 1
Lipids: 114793
- Membrane Lipids: 1591
  - Phospholipids: 11903
    - Glycerophosphates: 118
      - Phosphatidic Acids: 358
        Glycerophospholipids: 689
        Phosphatidylcholines: 2371
        folic acid-poly(ethyleneglycol)-2-distearoylglycero-3-phosphoethanolamine: 1

Experts

1.	Cheng, Ying: 1 article (08/2014)
2.	Cui, Han: 1 article (08/2014)
3.	Du, Jiang-bo: 1 article (08/2014)
4.	Liu, Dao-zhou: 1 article (08/2014)
5.	Liu, Miao: 1 article (08/2014)
6.	Song, Yan-feng: 1 article (08/2014)
7.	Ye, Wei-liang: 1 article (08/2014)
8.	Zhang, Bang-le: 1 article (08/2014)
9.	Zhou, Si-yuan: 1 article (08/2014)

Related Diseases

1.	Neoplasms (Cancer) 08/01/2014 - "These results indicated that modification of PLGA nanoparticles with FA-PEG-hyd-DSPE could considerably increase the drug-delivery efficiency and LPNs-1 had potential in the delivery of chemotherapeutic agents in the treatment of cancer. "